Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cefotetan Therapy for Escherichia Coli Bacteremia and Genitourinary Infections: a Prospective Phase II Pilot Study

NCT07318584 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07318584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07318584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cefotetan Therapy for Escherichia Coli Bacteremia and Genitourinary Infections: a Prospective Phase II Pilot Study
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
August 31, 2028
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

e coli infection, esbl producing e.coli